A potential peptide inhibitor of SARS-CoV-2 S and human ACE2 complex

References

• Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindah, E. (2015). Gromacs: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1–2, 19–25. https://doi.org/10.1016/j.softx.2015.06.001
   Google Scholar
• Alattar, R., Ibrahim, T. B. H., Shaar, S. H., Abdalla, S., Shukri, K., Daghfal, J. N., Khatib, M. Y., Aboukamar, M., Abukhattab, M., Alsoub, H. A., Almaslamani, M. A., & Omrani, A. S. (2020). Tocilizumab for the treatment of severe coronavirus disease 2019. Journal of Medical Virology, 92(10), 2042–2049. https://doi.org/10.1002/jmv.25964
   PubMed Web of Science ®Google Scholar
• Ali, A., & Vijayan, R. (2020). Dynamics of the ACE2–SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms. Scientific Reports, 10(1), 14214. https://doi.org/10.1038/s41598-020-71188-3
   PubMed Web of Science ®Google Scholar
• Baig, M. S., Alagumuthu, M., Rajpoot, S., & Saqib, U. (2020). Identification of a potential peptide inhibitor of SARS-CoV-2 targeting its entry into the host cells. Drugs in R and D, 20(3), 161–169. https://doi.org/10.1007/s40268-020-00312-5
   PubMed Web of Science ®Google Scholar
• Belouzard, S., Millet, J. K., Licitra, B. N., & Whittaker, G. R. (2012). Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses, 4(6), 1011–1033. https://doi.org/10.3390/v4061011
   PubMed Web of Science ®Google Scholar
• Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N., & Bourne, P. E. (2000). The protein data bank (www.rcsb.org). Nucleic Acids Research, 28(1), 235–242. https://doi.org/10.1093/nar/28.1.235
   PubMed Web of Science ®Google Scholar
• Bosch, B. J., van der Zee, R., de Haan, C. A. M., & Rottier, P. J. M. (2003). The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. Journal of Virology, 77(16), 8801–8811. https://doi.org/10.1128/JVI.77.16.8801-8811.2003
   PubMed Web of Science ®Google Scholar
• Brandman, R., Brandman, Y., & Pande, V. S. (2012). A-site residues move independently from P-site residues in all-atom molecular dynamics simulations of the 70S bacterial ribosome. PLoS One, 7(1), e29377. https://doi.org/10.1371/journal.pone.0029377
   PubMed Web of Science ®Google Scholar
• Cao, L., Goreshnik, I., Coventry, B., Case, J. B., Miller, L., Kozodoy, L., Chen, R. E., Carter, L., Walls, A. C., Park, Y. J., Strauch, E. M., Stewart, L., Diamond, M. S., Veesler, D., & Baker, D. (2020). De novo design of picomolar SARS-CoV-2 miniprotein inhibitors. Science, 370(6515), 426–431. https://doi.org/10.1126/science.abd9909
   PubMed Web of Science ®Google Scholar
• Casalino, L., Gaieb, Z., Goldsmith, J. A., Hjorth, C. K., Dommer, A. C., Harbison, A. M., Fogarty, C. A., Barros, E. P., Taylor, B. C., Mclellan, J. S., Fadda, E., & Amaro, R. E. (2020). Beyond shielding: The roles of glycans in the SARS-CoV-2 spike protein. ACS Central Science, 6(10), 1722–1734. https://doi.org/10.1021/acscentsci.0c01056
   PubMed Web of Science ®Google Scholar
• Chakrabartty, A., Kortemme, T., & Baldwin, R. L. (1994). Helix propensities of the amino acids measured in alanine-based peptides without helix-stabilizing side-chain interactions. Protein Science: A Publication of the Protein Society, 3(5), 843–852. https://doi.org/10.1002/pro.5560030514
   PubMed Web of Science ®Google Scholar
• Chandel, V., Raj, S., Rathi, B., & Kumar, D. (2020). In silico identification of potent FDA approved drugs against coronavirus COVID-19 main protease: A drug repurposing approach. Chemical Biology Letters, 7, 2347–9825. http://www.pubs.iscience.in/journal/index.php/cbl/article/view/1033/0
   Google Scholar
• Chong, H., Xue, J., Xiong, S., Cong, Z., Ding, X., Zhu, Y., Liu, Z., Chen, T., Feng, Y., He, L., Guo, Y., Wei, Q., Zhou, Y., Qin, C., & He, Y. (2017). A lipopeptide HIV-1/2 fusion inhibitor with highly potent in vitro, ex vivo, and in vivo antiviral activity. Journal of Virology, 91(11), 1–13. https://doi.org/10.1128/JVI.00288-17
   Google Scholar
• Coutard, B., Valle, C., de Lamballerie, X., Canard, B., Seidah, N. G., & Decroly, E. (2020). The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Research, 176, 104742. https://doi.org/10.1016/j.antiviral.2020.104742
   PubMed Web of Science ®Google Scholar
• de Vries, S. J., & Bonvin, A. M. J. J. (2011). Cport: A consensus interface predictor and its performance in prediction-driven docking with HADDOCK. PLoS One, 6(3), e17695. https://doi.org/10.1371/journal.pone.0017695
   PubMed Web of Science ®Google Scholar
• DeLano, W. L. (2002). The PyMOL molecular graphics system, version 1.1. Schr{ö}dinger LLC, https://doi.org/10.1038/hr.2014.17
   Google Scholar
• Dong, L., Hu, S., & Gao, J. (2020). Discovering drugs to treat coronavirus disease 2019 (COVID-19. Drug Discoveries & Therapeutics, 14(1), 58–60. https://doi.org/10.5582/ddt.2020.01012
   PubMed Web of Science ®Google Scholar
• Doytchinova, I. A., & Flower, D. R. (2007). VaxiJen: A server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics, 8(1), 1–7. https://doi.org/10.1186/1471-2105-8-4
   PubMedGoogle Scholar
• El-Manzalawy, Y., & Honavar, V. (2010). Recent advances in B-cell epitope prediction methods. Immunome Research, 6(2), 1–9. https://doi.org/10.1186/1745-7580-6-S2-S2
   Google Scholar
• Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010). Features and development of Coot. Acta Crystallographica Section D: Biological Crystallography, 66(6), 486–501. https://doi.org/10.1107/S0907444910007493
   PubMedGoogle Scholar
• Feldmann, M., Maini, R. N., Woody, J. N., Holgate, S. T., Winter, G., Rowland, M., Richards, D., & Hussell, T. (2020). Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed. The Lancet, 395(10234), 1407–1409. https://doi.org/10.1016/S0140-6736(20)30858-8
   PubMed Web of Science ®Google Scholar
• Fernandez, L., Bustos, R. H., Zapata, C., Garcia, J., Jauregui, E., & Ashraf, G. M. (2018). Immunogenicity in protein and peptide based-therapeutics: An overview. Current Protein & Peptide Science, 19(10), 958–971. https://doi.org/10.2174/1389203718666170828123449
   PubMed Web of Science ®Google Scholar
• Gao, J., Lu, G., Qi, J., Li, Y., Wu, Y., Deng, Y., Geng, H., Li, H., Wang, Q., Xiao, H., Tan, W., Yan, J., & Gao, G. F. (2013). Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the S protein of middle east respiratory syndrome coronavirus. Journal of Virology, 87(24), 13134–13140. https://doi.org/10.1128/JVI.02433-13
   PubMed Web of Science ®Google Scholar
• Gupta, S., Kapoor, P., Chaudhary, K., Gautam, A., Kumar, R., & Raghava, G. P. S, Open Source Drug Discovery Consortium (2013). In silico approach for predicting toxicity of peptides and proteins. PLoS One, 8(9), e73957. https://doi.org/10.1371/journal.pone.0073957
   PubMed Web of Science ®Google Scholar
• Han, D. P., Penn-Nicholson, A., & Cho, M. W. (2006). Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor. Virology, 350(1), 15–25. https://doi.org/10.1016/j.virol.2006.01.029
   PubMed Web of Science ®Google Scholar
• Han, Y., & Král, P. (2020). Computational design of ACE2-based peptide inhibitors of SARS-CoV-2. ACS Nano, 14(4), 5143–5147. https://doi.org/10.1021/acsnano.0c02857
   PubMed Web of Science ®Google Scholar
• Ho, T. Y., Wu, S. L., Chen, J. C., Wei, Y. C., Cheng, S. E., Chang, Y. H., Liu, H. J., & Hsiang, C. Y. (2006). Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction. Antiviral Research, 69(2), 70–76. https://doi.org/10.1016/j.antiviral.2005.10.005
   PubMed Web of Science ®Google Scholar
• Hoffmann, M., Kleine-Weber, H., & Pöhlmann, S. (2020). A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells. Molecular Cell, 78(4), 779–784. https://doi.org/10.1016/j.molcel.2020.04.022
   PubMed Web of Science ®Google Scholar
• Huang, X., Pearce, R., & Zhang, Y. (2020). De novo design of protein peptides to block association of the SARS-CoV-2 spike protein with human ACE2. Aging, 12(12), 11263–11276. https://doi.org/10.18632/aging.103416
   PubMedGoogle Scholar
• Jaiswal, G., & Kumar, V. (2020). In-silico design of a potential inhibitor of SARS-CoV-2 S protein. PLOS One, 15(10), e0240004. https://doi.org/10.1371/journal.pone.0240004
   PubMed Web of Science ®Google Scholar
• Jo, S., Kim, T., Iyer, V. G., & Im, W. (2008). CHARMM-GUI: A web-based graphical user interface for CHARMM. Journal of Computational Chemistry, 29(11), 1859–1865. https://doi.org/10.1002/jcc.20945
   PubMed Web of Science ®Google Scholar
• Khan, R. J., Jha, R. K., Amera, G. M., Jain, M., Singh, E., Pathak, A., Singh, R. P., Muthukumaran, J., & Singh, A. K. (2020). Targeting SARS-CoV-2: A systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2’-O-ribosemethyltransferase. Journal of Biomolecular Structure & Dynamics, 1–14. https://doi.org/10.1080/07391102.2020.1753577
   Web of Science ®Google Scholar
• Kringelum, J. V., Lundegaard, C., Lund, O., & Nielsen, M. (2012). Reliable B cell epitope predictions: Impacts of method development and improved benchmarking. PLoS Computational Biology, 8(12), e1002829. https://doi.org/10.1371/journal.pcbi.1002829
   PubMed Web of Science ®Google Scholar
• Kumar, S., Maurya, V. K., Prasad, A. K., Bhatt, M. L. B., & Saxena, S. K. (2020). Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV. Virusdisease, 31(1), 13–21. https://doi.org/10.1007/s13337-020-00571-5
   PubMedGoogle Scholar
• Lan, J., Ge, J., Yu, J., Shan, S., Zhou, H., Fan, S., Zhang, Q., Shi, X., Wang, Q., Zhang, L., & Wang, X. (2020). Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature, 581(7807), 215–220. https://doi.org/10.1038/s41586-020-2180-5
   PubMed Web of Science ®Google Scholar
• Larsen, M. v., Lundegaard, C., Lamberth, K., Buus, S., Lund, O., & Nielsen, M. (2007). Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC Bioinformatics, 8(1), 424. https://doi.org/10.1186/1471-2105-8-424
   PubMed Web of Science ®Google Scholar
• Lee, J., Cheng, X., Swails, J. M., Yeom, M. S., Eastman, P. K., Lemkul, J. A., Wei, S., Buckner, J., Jeong, J. C., Qi, Y., Jo, S., Pande, V. S., Case, D. A., Brooks, C. L., MacKerell, A. D., Klauda, J. B., & Im, W. (2016). CHARMM-GUI input generator for NAMD, GROMACS, AMBER, openMM, and CHARMM/OpenMM simulations using the CHARMM36 additive force field. Journal of Chemical Theory and Computation, 12(1), 405–413. https://doi.org/10.1021/acs.jctc.5b00935
   PubMed Web of Science ®Google Scholar
• Lenci, E., & Trabocchi, A. (2020). Peptidomimetic toolbox for drug discovery. Chemical Society Reviews, 49(11), 3262–3277. https://doi.org/10.1039/D0CS00102C
   PubMed Web of Science ®Google Scholar
• Li, F. (2015). Receptor recognition mechanisms of coronaviruses: A decade of structural studies. Journal of Virology, 89(4), 1954–1964. https://doi.org/10.1128/JVI.02615-14
   PubMed Web of Science ®Google Scholar
• Li, F. (2016). Structure, function, and evolution of coronavirus spike proteins. Annual Review of Virology, 3(1), 237–261. https://doi.org/10.1146/annurev-virology-110615-042301
   PubMed Web of Science ®Google Scholar
• Li, F., Li, W., Farzan, M., & Harrison, S. C. (2005). Structural biology: Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science, 309(5742), 1864–1868. https://doi.org/10.1126/science.1116480
   PubMed Web of Science ®Google Scholar
• Li, W., Greenough, T. C., Moore, M. J., Vasilieva, N., Somasundaran, M., Sullivan, J. L., Farzan, M., & Choe, H. (2004). Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2. Journal of Virology, 78(20), 11429–11433. https://doi.org/10.1128/JVI.78.20.11429-11433.2004
   PubMed Web of Science ®Google Scholar
• Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., Choe, H., & Farzan, M. (2003). Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. Nature, 426(6965), 450–454. https://doi.org/10.1038/nature02145
   PubMed Web of Science ®Google Scholar
• Mirza, M. U., & Froeyen, M. (2020). Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal potential drug candidates against main protease, Nsp12 RNA-dependent RNA polymerase and Nsp13 helicase. Journal of pharmaceutical analysis, 10(4), 320–328. https://doi.org/10.20944/preprints202003.0085.v1
   PubMed Web of Science ®Google Scholar
• Parker, D. C. (2016). T cell-dependent B cell activation. Encyclopedia of Immunobiology. https://doi.org/10.1016/B978-0-12-374279-7.09010-X
   Google Scholar
• Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF Chimera-a visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25(13), 1605–1612. https://doi.org/10.1002/jcc.20084
   PubMed Web of Science ®Google Scholar
• Potocnakova, L., Bhide, M., & Pulzova, L. B. (2016). An introduction to B-cell epitope mapping and in silico epitope prediction. Journal of Immunology Research, 2016, 6760830. https://doi.org/10.1155/2016/6760830
   PubMed Web of Science ®Google Scholar
• Rath, S. L., & Kumar, K. (2020). Investigation of the effect of temperature on the structure of SARS-CoV-2 spike protein by molecular dynamics aimulations. Frontiers in Molecular Biosciences, 7, 583523. https://doi.org/10.3389/fmolb.2020.583523
   PubMed Web of Science ®Google Scholar
• Ren, L. L., Wang, Y. M., Wu, Z. Q., Xiang, Z. C., Guo, L., Xu, T., Jiang, Y. Z., Xiong, Y., Li, Y. J., Li, X. W., Li, H., Fan, G. H., Gu, X. Y., Xiao, Y., Gao, H., Xu, J. Y., Yang, F., Wang, X. M., Wu, C., … Wang, J. W. (2020). Identification of a novel coronavirus causing severe pneumonia in human: A descriptive study. Chinese Medical Journal, 133(9), 1015–1024. https://doi.org/10.1097/CM9.0000000000000722
   PubMed Web of Science ®Google Scholar
• Roccatano, D., Barthel, A., & Zacharias, M. (2007). Structural flexibility of the nucleosome core particle at atomic resolution studied by molecular dynamics simulation. Biopolymers, 85(5–6), 407–421. https://doi.org/10.1002/bip.20690
   PubMed Web of Science ®Google Scholar
• Sanchez-Garcia, R., Sorzano, C. O. S., Carazo, J. M., & Segura, J. (2019). BIPSPI: A method for the prediction of partner-specific protein-protein interfaces. Bioinformatics, 35(3), 470–477. https://doi.org/10.1093/bioinformatics/bty647
   PubMed Web of Science ®Google Scholar
• Sanchez-Trincado, J. L., Gomez-Perosanz, M., & Reche, P. A. (2017). Fundamentals and methods for T- and B-cell epitope prediction. Journal of Immunology Research, 2017, 2680160. https://doi.org/10.1155/2017/2680160
   PubMed Web of Science ®Google Scholar
• Shang, J., Ye, G., Shi, K., Wan, Y., Luo, C., Aihara, H., Geng, Q., Auerbach, A., & Li, F. (2020). Structural basis of receptor recognition by SARS-CoV-2. Nature, 581(7807), 221–224. https://doi.org/10.1038/s41586-020-2179-y
   PubMed Web of Science ®Google Scholar
• Sharma, S., Ding, F., & Dokholyan, N. v. (2007). Multiscale modeling of nucleosome dynamics. Biophysical Journal, 92(5), 1457–1470. https://doi.org/10.1529/biophysj.106.094805
   PubMed Web of Science ®Google Scholar
• Simmons, G., Reeves, J. D., Rennekamp, A. J., Amberg, S. M., Piefer, A. J., & Bates, P. (2004). Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proceedings of the National Academy of Sciences of the United States of America, 101(12), 4240–4245. https://doi.org/10.1073/pnas.0306446101
   PubMed Web of Science ®Google Scholar
• Spaan, W., Cavanagh, D., & Horzinek, M. C. (1988). Coronaviruses: Structure and genome expression. Journal of General Virology, 69(12), 2939–2952. https://doi.org/10.1099/0022-1317-69-12-2939
   PubMedGoogle Scholar
• Tai, W., He, L., Zhang, X., Pu, J., Voronin, D., Jiang, S., Zhou, Y., & Du, L. (2020). Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: Implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cellular and Molecular Immunology, 17(6), 613–620. https://doi.org/10.1038/s41423-020-0400-4
   PubMed Web of Science ®Google Scholar
• Thanh Le, T., Andreadakis, Z., Kumar, A., Gómez Román, R., Tollefsen, S., Saville, M., & Mayhew, S. (2020). The COVID-19 vaccine development landscape. Nature reviews Drug discovery, 19(5), 305–306. https://doi.org/10.1038/d41573-020-00073-5
   Google Scholar
• Tian, X., Li, C., Huang, A., Xia, S., Lu, S., Shi, Z., Lu, L., Jiang, S., Yang, Z., Wu, Y., & Ying, T. (2020). Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Emerging Microbes and Infections, 9(1), 382–385. https://doi.org/10.1080/22221751.2020.1729069
   Google Scholar
• Tinoco, I., & J. der, W. (2009). Simulation and analysis of single-ribosome translation. Physical Biology, 6(2), 025006. https://doi.org/10.1088/1478-3975/6/2/025006
   PubMed Web of Science ®Google Scholar
• Vagner, J., Qu, H., & Hruby, V. J. (2008). Peptidomimetics, a synthetic tool of drug discovery. Current Opinion in Chemical Biology, 12(3), 292–296. https://doi.org/10.1016/j.cbpa.2008.03.009
   PubMed Web of Science ®Google Scholar
• van Zundert, G. C. P., Rodrigues, J. P. G. L. M., Trellet, M., Schmitz, C., Kastritis, P. L., Karaca, E., Melquiond, A. S. J., van Dijk, M., de Vries, S. J., & Bonvin, A. M. J. J. (2016). The HADDOCK2.2 web server: User-friendly integrative modeling of biomolecular complexes. Journal of Molecular Biology, 428(4), 720–725. https://doi.org/10.1016/j.jmb.2015.09.014
   PubMed Web of Science ®Google Scholar
• Vilas Boas, L. C. P., Campos, M. L., Berlanda, R. L. A., de Carvalho Neves, N., & Franco, O. L. (2019). Antiviral peptides as promising therapeutic drugs. Cellular and Molecular Life Sciences, 76(18), 3525–3542. https://doi.org/10.1007/s00018-019-03138-w
   PubMed Web of Science ®Google Scholar
• Walls, A. C., Park, Y. J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020). Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell, 181(2), 281–292. https://doi.org/10.1016/j.cell.2020.02.058
   PubMed Web of Science ®Google Scholar
• Walls, A. C., Tortorici, M. A., Frenz, B., Snijder, J., Li, W., Rey, F. A., DiMaio, F., Bosch, B. J., & Veesler, D. (2016). Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy. Nature Structural and Molecular Biology, 23(10), 899–905. https://doi.org/10.1038/nsmb.3293
   PubMed Web of Science ®Google Scholar
• Wan, Y., Shang, J., Graham, R., Baric, R. S., & Li, F. (2020). Receptor recognition by the novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS coronavirus. Journal of Virology, 94(7), e00127–20. https://doi.org/10.1128/JVI.00127-20
   PubMed Web of Science ®Google Scholar
• Weng, G., Wang, E., Wang, Z., Liu, H., Zhu, F., Li, D., & Hou, T. (2019). HawkDock: A web server to predict and analyze the protein-protein complex based on computational docking and MM/GBSA. Nucleic Acids Research, 47(W1), W322–W330. https://doi.org/10.1093/nar/gkz397
   PubMed Web of Science ®Google Scholar
• Wójcik, P., & Berlicki, Ł. (2016). Peptide-based inhibitors of protein–protein interactions. Bioorganic and Medicinal Chemistry Letters, 26(3):707–713. https://doi.org/10.1016/j.bmcl.2015.12.084
   Google Scholar
• Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C. L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020). Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science, 367(6483), 1260–1263. https://doi.org/10.1126/science.aax0902 https://doi.org/10.1126/science.abb2507
   PubMed Web of Science ®Google Scholar
• Wu, C., Liu, Y., Yang, Y., Zhang, P., Zhong, W., Wang, Y., Wang, Q., Xu, Y., Li, M., Li, X., Zheng, M., Chen, L., & Li, H. (2020). Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharmaceutica Sinica. B, 10(5), 766–788. https://doi.org/10.1016/j.apsb.2020.02.008
   PubMed Web of Science ®Google Scholar
• Wu, F., Zhao, S., Yu, B., Chen, Y. M., Wang, W., Song, Z. G., Hu, Y., Tao, Z. W., Tian, J. H., Pei, Y. Y., Yuan, M. L., Zhang, Y. L., Dai, F. H., Liu, Y., Wang, Q. M., Zheng, J. J., Xu, L., Holmes, E. C., & Zhang, Y. Z. (2020). A new coronavirus associated with human respiratory disease in China. Nature, 579(7798), 265–269. https://doi.org/10.1038/s41586-020-2008-3
   PubMed Web of Science ®Google Scholar
• Xia, S., Zhu, Y., Liu, M., Lan, Q., Xu, W., Wu, Y., Ying, T., Liu, S., Shi, Z., Jiang, S., & Lu, L. (2020). Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein. Cellular and Molecular Immunology, 17(7):765–767 https://doi.org/10.1038/s41423-020-0374-2
   Google Scholar
• Xue, L. C., Rodrigues, J. P., Kastritis, P. L., Bonvin, A. M., & Vangone, A. (2016). PRODIGY: A web server for predicting the binding affinity of protein–protein complexes. Bioinformatics, 32(23):3676–3678. https://doi.org/10.1093/bioinformatics/btw514
   PubMed Web of Science ®Google Scholar
• Yan, R., Zhang, Y., Li, Y., Xia, L., Guo, Y., & Zhou, Q. (2020). Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science, 367(6485), 1444–1448. https://doi.org/10.1126/science.abb2762
   PubMed Web of Science ®Google Scholar
• Yang, L. W., Eyal, E., Bahar, I., & Kitao, A. (2009). Principal component analysis of native ensembles of biomolecular structures (PCA_NEST): Insights into functional dynamics. Bioinformatics, 25(5), 606–614. https://doi.org/10.1093/bioinformatics/btp023
   PubMed Web of Science ®Google Scholar
• Zhang, G., Pomplun, S., Loftis, A. R., Tan, X., Loas, A., & Pentelute, B. L. (2020). Investigation of ACE2 N-terminal fragments binding to SARS-CoV-2 Spike RBD. BioRxiv.
   Google Scholar
• Zhou, P., Yang, X. L., Wang, X. G., Hu, B., Zhang, L., Zhang, W., Si, H. R., Zhu, Y., Li, B., Huang, C. L., Chen, H.D., Chen, J., Luo, Y., Guo, H., Jiang, R. D., Liu, M. Q., Chen, Y., Shen, X. R., Wang, X., & Shi, Z. L. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 588(7836), E6–E6. https://doi.org/10.1038/s41586-020-2012-7
   PubMed Web of Science ®Google Scholar
• Zhou, Y., Hou, Y., Shen, J., Huang, Y., Martin, W., & Cheng, F. (2020). Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discovery, 6(1):14. https://doi.org/10.1038/s41421-020-0153-3
   PubMed Web of Science ®Google Scholar
• Zhou, Z., Post, P., Chubet, R., Holtz, K., McPherson, C., Petric, M., & Cox, M. (2006). A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice. Vaccine, 24(17), 3624–3631. https://doi.org/10.1016/j.vaccine.2006.01.059
   PubMed Web of Science ®Google Scholar
• Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G. F., & Tan, W, China Novel Coronavirus Investigating and Research Team. (2020). A novel coronavirus from patients with pneumonia in China, 2019. The New England Journal of Medicine, 382(8), 727–733. https://doi.org/10.1056/NEJMoa2001017
   PubMed Web of Science ®Google Scholar